MEGAN HARRIS: Open Payments
NPI 1013260793 · SUGARLOAF, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,762 in 90 payments from 14 companies in 2025. Trend: 2023 $72 · 2024 $2,203 · 2025 $1,762
Food & beverage: $1,752Education: $10
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $702 |
| ABBVIE INC. | 36 | $438 |
| Galderma Laboratories, L.P. | 10 | $169 |
| Novartis Pharmaceuticals Corporation | 7 | $124 |
| Regeneron Healthcare Solutions, Inc. | 2 | $73 |
| GENZYME CORPORATION | 2 | $59 |
| LEO Pharma Inc. | 2 | $57 |
| UCB, Inc. | 1 | $28 |
| Abbott Laboratories | 1 | $26 |
| PFIZER INC. | 1 | $19 |
Products named: TREMFYA, SKYRIZI, RINVOQ, DUPIXENT, COSENTYX, NEMLUVIO, ANZUPGO, Rhapsido.
Industry payments across PA — which companies pay providers there.
